KP Tissue Inc. (TSE:KPT – Free Report) – Desjardins issued their Q1 2025 earnings estimates for shares of KP Tissue in a research report issued on Thursday, March 6th. Desjardins analyst F. Tremblay expects that the company will earn $0.12 per share for the quarter. Desjardins has a “Hold” rating and a $8.50 price target on the stock. The consensus estimate for KP Tissue’s current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue’s Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.10 EPS, Q4 2025 earnings at $0.12 EPS and FY2026 earnings at $0.56 EPS.
Separately, CIBC cut their price objective on KP Tissue from C$9.00 to C$8.50 in a report on Wednesday, January 15th.
KP Tissue Stock Performance
TSE KPT opened at C$8.02 on Monday. The firm’s fifty day moving average price is C$8.03 and its two-hundred day moving average price is C$8.21. The stock has a market cap of C$80.15 million, a PE ratio of 12.56, a PEG ratio of -0.88 and a beta of 0.37. KP Tissue has a fifty-two week low of C$7.66 and a fifty-two week high of C$9.05.
About KP Tissue
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
See Also
- Five stocks we like better than KP Tissue
- Retail Stocks Investing, Explained
- How to Protect Your Portfolio When Inflation Is Rising
- How to Capture the Benefits of Dividend Increases
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.